Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02427776
What this trial is testing

A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Imcyse SA 2
Post-approval studies (Phase 4)Study completedNCT05084638
What this trial is testing

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

Who this might be right for
Relapse Remitting Multiple Sclerosis
Novartis Pharmaceuticals 180
Not applicableUnknownNCT04857489
What this trial is testing

Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapse Remitting Multiple Sclerosis
Thomas Jefferson University 80
Not applicableStudy completedNCT05304520
What this trial is testing

Tysabri Participant Preference

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Biogen 318
Post-approval studies (Phase 4)Ended earlyNCT02217982
What this trial is testing

Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Rocky Mountain MS Research Group, LLC 5
Testing effectiveness (Phase 2)WithdrawnNCT00986960
What this trial is testing

Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University at Buffalo
Not applicableStudy completedNCT01075880
What this trial is testing

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 300
Testing effectiveness (Phase 2)Study completedNCT00202982
What this trial is testing

Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Who this might be right for
Relapse-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00228397
What this trial is testing

Study Evaluating CCI-779 in Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Wyeth is now a wholly owned subsidiary of Pfizer 221
Testing effectiveness (Phase 2)Ended earlyNCT01039103
What this trial is testing

Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Acute Exacerbation of Remitting Relapsing Multiple SclerosisClinically Isolated Syndrome
Lakefront Biotherapeutics NV 15
Early research (Phase 1)UnknownNCT04178980
What this trial is testing

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Simvastatin Multiple Sclerosis
Assiut University 60
Early research (Phase 1)Study completedNCT02506751
What this trial is testing

Open-label Study of Liothyronine in MS

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
Johns Hopkins University 20
Post-approval studies (Phase 4)Study completedNCT01591551
What this trial is testing

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Cornerstone Health Care, PA 37
Not applicableStudy completedNCT01080053
What this trial is testing

Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Merck KGaA, Darmstadt, Germany 306
Not applicableStudy completedNCT06854341
What this trial is testing

A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Novartis Pharmaceuticals 5,448
Large-scale testing (Phase 3)Study completedNCT00530348
What this trial is testing

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genzyme, a Sanofi Company 581
Not applicableStudy completedNCT03464448
What this trial is testing

Mechanistic Studies of Teriflunomide in RRMS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of Michigan 30
Testing effectiveness (Phase 2)Ended earlyNCT02418325
What this trial is testing

Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genesis Limited 69
Not applicableStudy completedNCT02696590
What this trial is testing

High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Isfahan University of Medical Sciences 200
Not applicableLooking for participantsNCT07222618
What this trial is testing

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+3 more
University of California, San Francisco 300
Next Page